Skip to main content
SpringerLink
Log in

Ebastine in Context

Introduction

  • Published:
Drugs Aims and scope Submit manuscript

Summary

The allergic reaction to a specific antigen is characterised by a series of complex immunological processes consisting of an early specific immune response and a late inflammatory reaction.

The release of active substances (principally histamine) from cytoplasmic granules of mast cells and basophils in response to antigen challenge is responsible for many of the symptoms observed in the early phase of the allergic reaction.

The late phase inflammatory reaction caused by the recruitment of inflammatory cells (mainly eosinophils) to the area of initial antigen challenge and the consequent release of soluble factors result in amplification and prolongation of allergic symptoms.

Antihistamines are the most widely used drugs for the treatment of allergic conditions. These agents act on both the early immune response (by blocking the action of histamine at the H1 receptor) and also demonstrate anti-inflammatory effects. Second generation antihistamines are free of the sedative and anticholinergic effects characteristic of the first generation agents. Ebastine, the focus of this supplement, is a new second generation agent that has shown antihistamine activity in preclinical studies and clinical efficacy in providing relief from symptoms in patients with allergic disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Referenc

  1. Dale MM, Foreman JC, Fan T-PD. Introduction to the immunology and pathology of host defence mechanisms. In: Dale MM, Foreman JC, Fan T-PD, editors. Textbook of Immuno-pharmacology. 3rd ed., chp. 5. Boston: Blackwell Scientific Publications, 1994: 1–17.

    Google Scholar 

  2. Frew AJ. Cytokines, chemokines, T cells and allergy. Clin Exp Allergy 1996; 26: 2–4.

    Article  PubMed  CAS  Google Scholar 

  3. Schroeder JT, Kagey-Sobotka A, Lichtenstein LM. The role of the basophil in allergic inflammation. Allergy 1995; 50: 463–72.

    Article  PubMed  CAS  Google Scholar 

  4. Bradding P. Human mast cell cytokines. Clin Exp Allergy 1996; 26: 13–9.

    Article  PubMed  CAS  Google Scholar 

  5. Foreman JC. Mast cells and basophil leucocytes. In: Dale MM, Foreman JC, Fan T-PD, editors. Textbook of Immunopharmacology. 3rd ed., chp. 5. Boston: Blackwell Scientific Publications, 1994: 21–34.

    Google Scholar 

  6. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol 1990; 86 Suppl.: 599–605.

    Article  PubMed  CAS  Google Scholar 

  7. Wasserman SI. Mast cell biology. J Allergy Clin Immunol 1990; 86 Suppl.: 590–3.

    Article  PubMed  CAS  Google Scholar 

  8. White MV, Kaliner MA. Mediators of allergic rhinitis. J Allergy Clin Immunol 1992; 90: 699–704.

    Article  PubMed  CAS  Google Scholar 

  9. Wilkinson PC. Cellular accumulation and inflammation. In: Dale MM, Foreman JC, Fan T-PD, editors. Textbook of Immunopharmacology. 3rd ed., chp. 5. Boston: Blackwell Scientific Publications, 1994: 218–31.

    Google Scholar 

  10. Wardlaw AJ, Symon FS, Walsh GM. Eosinophil adhesion in allergic inflammation. J Allergy Clin Immunol 1994; 94: 1163–71.

    Article  PubMed  CAS  Google Scholar 

  11. Denburg JA, Woolley M, Leber B, et al. Basophil and eosinophil differentiation in allergic reactions. J Allergy Clin Immunol 1994; 94: 1135–41.

    Article  PubMed  CAS  Google Scholar 

  12. Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 1996; 97: 104–12.

    Article  PubMed  CAS  Google Scholar 

  13. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking and inflammation. Curr Opin Immunol 1994; 6: 865–73.

    Article  PubMed  CAS  Google Scholar 

  14. Wardlaw AJ, Moqbel R, Kay AB. The eosinophil leukocyte. In Dale MM, Foreman JC, Fan T-PD, editors. Textbook of Immunopharmacology. 3rd ed., chp. 5. Boston: Blackwell Scientific Publications, 1994: 55–63.

    Google Scholar 

  15. Moqbel R, Levi-Schaffer F, Kay AB. Cytokine generation by eosinophils. J Allergy Clin Immunol 1994; 94: 1183–8.

    Article  PubMed  CAS  Google Scholar 

  16. Dale HH, Laidlaw PP. Histamine shock. J Physiol 1919; 52: 355–390.

    PubMed  CAS  Google Scholar 

  17. Dale MM, Foreman JC. Histamine as a mediator of allergic and inflammatory reactions. In: Dale MM, Foreman JC, Fan T-PD, editors. Textbook of Immunopharmacology. 3rd ed., chp. 5. Boston: Blackwell Scientific Publications, 1994: 122–30.

    Google Scholar 

  18. Rimmer SJ, Church MK. The pharmacology and mechanisms of action of histamine H1-antagonists. Clin Exp Allergy 1990; 20 Suppl. 2: 3–17.

    Article  PubMed  Google Scholar 

  19. Arunlakshana O, Schild HO. Histamine release by antihistamines. J Physiol (Lond) 1953; 119: 47–8.

    Google Scholar 

  20. Mota I, Dias Da Silva W. The antianaphylactic and histamine releasing properties of the anti-histamines: their effect on mast cells. Br J Pharmacol 1960; 15: 396–404.

    CAS  Google Scholar 

  21. Lichtenstein LM, Gillespie E. The effects of the H1 and H2 antihistamines on ‘allergic’ histamine release and its inhibition by histamine. J Pharmacol Exp Ther 1972; 192: 441–50.

    Google Scholar 

  22. Church MK, Gradidge CF. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs. Br J Pharmacol 1980; 69: 663–7.

    Article  PubMed  CAS  Google Scholar 

  23. Simons FER. The antiallergic effects of antihistamines (H1-receptor antagonists). J Allergy Clin Immunol 1992; 90: 705–15.

    Article  PubMed  CAS  Google Scholar 

  24. Townley RG. Antiallergic properties of the second generation H1 antihistamines during the early and late reactions to antigen. J Allergy Clin Immunol 1992; 90 Suppl.: 720–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital Duran i Reinals, Autovía Castelldefels km 2,7, 08907, L’Hospitalet de Llobregat, Barcelona, Spain

    Enrique Buendia

Authors
  1. Enrique Buendia
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buendia, E. Ebastine in Context. Drugs 52 (Suppl 1), 1–7 (1996). https://doi.org/10.2165/00003495-199600521-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199600521-00003

Keywords

Search

Navigation